Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin-2

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology 2004-02, Vol.11 (S2), p.S77-S77
Main Authors: Spanknebel, K., Hurst-Wicker, K., Cheung, Y. K., Hesdorffer, C., DeRaffele, G., Kaufman, H.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1068-9265
1534-4681
DOI:10.1007/BF02524054